Redsense Medical attending Home Dialysis Congress in Germany
Redsense Medical will be participating and exhibiting at the 14th Cologne Home Dialysis Congress of the KfH. The event takes places April 26-27, 2024, in Cologne, Germany.
The Congress is organized by KfH, the largest dialysis provider in Germany with 6 400 employees. As a non-profit organization, KfH provides dialysis to around 18 000 patients. KfH has recognized home dialysis as an important area to improve quality of care and life of dialysis patients.
The Congress will offer the latest information and findings from Germany and abroad as well as practice-oriented lectures and workshops with international speakers. In the accompanying partner forum, almost all new developments in the field of renal replacement therapy with focus on treatment at home and the training of home dialysis patients will be exhibited.
“We look forward to participating and presenting the Redsense Alarm System as well as the upcoming Clamp. The Redsense Clamp is planned to be launched later this year and this Congress presents an excellent opportunity to introduce it to the largest non-profit provider in Germany.” says Sebastien Bollue, COO of Redsense Medical attending the Congress.
For further information about the event, please visit: https://heimdialysekongress.kfh.de
Contact information
For more information, please contact:
Pontus Nobréus, CEO
Telephone: +46 72-171 1264
E-mail: pontus.nobreus (at) redsensemedical.com
Redsense Medical AB (publ), 556646-4862
ABOUT REDSENSE MEDICAL
Redsense Medical is a corporate group with operations mainly in Europe and the United States. The company has developed the Redsense System, an innovation used for monitoring and alarm in the case of blood leakage in connection with a hemodialysis treatment. Redsense Medical solves one of the most serious remaining safety problems within hemodialysis – to quickly detect Venous Needle Dislodgement and catheter leakage to minimize blood leakage. The system consists of a patented fiber optic sensor, designed for either venous needle or central venous catheter, which is connected to an alarm unit. From the very start, the development of the company's technology has been based on the demands and safety requirements of healthcare providers in the dialysis sector. The Redsense Medical share is listed on Spotlight Stock Market (REDS) and traded on OTCQX (RDSNF) in the US.